Absci (ABSI) shares were more than 17% lower pre-bell Friday after the company said late Thursday it priced a $50 million stock offering.
Centene (CNC) stock was down 12%, a day after the company reported it swung to a Q2 adjusted loss.
Sarepta Therapeutics (SRPT) shares were nearly 12% lower after the Brazilian Health Regulatory Agency late Thursday temporarily suspended the company's gene therapy drug Elevidys.
OneConstruction Group (ONEG) stock was down 14%, erasing Thursday's gains.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。